StoneX Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,232
Closed -$256K 977
2025
Q4
$256K Sell
3,232
-2,978
-48% -$233K 0.01% 769
2025
Q3
$496K Sell
6,210
-308
-5% -$26.3K 0.02% 538
2025
Q2
$592K Sell
6,518
-157
-2% -$14.3K 0.03% 450
2025
Q1
$625K Sell
6,675
-256
-4% -$22.9K 0.03% 417
2024
Q4
$630K Buy
6,931
+1,873
+37% +$179K 0.03% 405
2024
Q3
$525K Buy
5,058
+2,067
+69% +$211K 0.24% 119
2024
Q2
$290K Buy
2,991
+312
+12% +$28.8K 0.14% 216
2024
Q1
$241K Sell
2,679
-663
-20% -$56.2K 0.12% 238
2023
Q4
$266K Sell
3,342
-30
-0.9% -$2.26K 0.14% 212
2023
Q3
$240K Buy
3,372
+177
+6% +$13.2K 0.13% 241
2023
Q2
$246K Buy
3,195
+259
+9% +$20K 0.14% 235
2023
Q1
$221K Buy
2,936
+221
+8% +$16.4K 0.13% 261
2022
Q4
$214K Buy
+2,715
New +$204K 0.03% 390
2022
Q2
Sell
-3,065
Closed -$232K 559
2022
Q1
$232K Buy
3,065
+592
+24% +$46.9K 0.02% 478
2021
Q4
$211K Buy
+2,473
New +$193K 0.02% 506

Other funds holding CL

StoneX Group's CL Position: Q1 2026 in Review

StoneX Group sold out of Colgate-Palmolive (CL) in Q1 2026, closing a stake of 3,232 shares — an estimated $256K sold.

StoneX Group first reported a position in CL in Q4 2021 and held it in 15 quarters. The position peaked at $630K in Q4 2024. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • StoneX Group reported no remaining Colgate-Palmolive position as of Q1 2026 after selling out during the quarter.
  • StoneX Group sold 3,232 Colgate-Palmolive shares in Q1 2026, an estimated $256K.
  • StoneX Group first reported a position in Colgate-Palmolive in Q4 2021 and held it in 15 quarters.
  • StoneX Group's Colgate-Palmolive position peaked at $630K in Q4 2024.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on StoneX Group's 13F filing for Q1 2026, filed 14 May 2026.